Pharma Tech Co. Targets Rival Over Tracking Device IP
Fuisz Pharma's suit alleges that handheld devices manufactured by Theranos used to detect drug-induced changes to a patient's biomedical markers and communicate the results to medical personnel violate U.S. Patent No. 7,824,612. Fuisz Pharma seeks an injunction, damages, pre- and post-judgment interest, attorneys' fees and a trial by jury.
“Theranos' acts have causes and,...
To view the full article, register now.